Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Deferred Taxes: 2023-2025

Historic Deferred Taxes for Organogenesis Holdings (ORGO) over the last 1 years, with Sep 2025 value amounting to -$3.8 million.

  • Organogenesis Holdings' Deferred Taxes fell 74.57% to -$3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.0 million, marking a year-over-year change of. This contributed to the annual value of -$10.7 million for FY2024, which is 423.74% down from last year.
  • As of Q3 2025, Organogenesis Holdings' Deferred Taxes stood at -$3.8 million, which was down 273.98% from -$1.0 million recorded in Q2 2025.
  • Organogenesis Holdings' 5-year Deferred Taxes high stood at $3.3 million for Q4 2023, and its period low was -$3.8 million during Q3 2025.
  • Over the past 3 years, Organogenesis Holdings' median Deferred Taxes value was -$1.7 million (recorded in 2024), while the average stood at -$1.3 million.
  • Data for Organogenesis Holdings' Deferred Taxes shows a maximum YoY slumped of 185.53% (in 2024) over the last 5 years.
  • Organogenesis Holdings' Deferred Taxes (Quarterly) stood at $3.3 million in 2023, then tumbled by 185.53% to -$2.8 million in 2024, then crashed by 74.57% to -$3.8 million in 2025.
  • Its Deferred Taxes was -$3.8 million in Q3 2025, compared to -$1.0 million in Q2 2025 and -$1.3 million in Q1 2025.